DT-diaphorase and cancer chemotherapy.
Riley
R J
RJ
Department of Medical Oncology, CRC Beatson Laboratories, University of Glasgow, U.K.
Workman
P
P
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry*; D001388:Aziridines / Q000737:chemistry; D016227:Benzoquinones / Q000737:chemistry; D008058:Dihydrolipoamide Dehydrogenase / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics; D015195:Drug Design; D004790:Enzyme Induction; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D045563:Indolequinones; D007211:Indoles / Q000737:chemistry; D016685:Mitomycin / Q000737:chemistry; D009369:Neoplasms / Q000201:enzymology*; D011230:Precancerous Conditions / Q000201:enzymology*; D000077704:Tirapazamine; D014227:Triazines / Q000737:chemistry
D000970:Antineoplastic Agents; D001388:Aziridines; D016227:Benzoquinones; D045563:Indolequinones; D007211:Indoles; D014227:Triazines; D000077704:Tirapazamine; D016685:Mitomycin; C100099:tretazicar; D008058:Dihydrolipoamide Dehydrogenase; C029108:diaziquone; C060817:apaziquone